secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2026-05-26T13:03:51+00:00
Accession:  0000926617-26-000037
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health enters collaboration with Cleveland Clinic for AI-powered diagnostics
--------------------------------------------------------------------------------

- Partnering fee of $125,000; $50,000 due within 30 days, then $25,000 on each of first three anniversaries.
- Collaboration focuses on biomarker discovery, AI-driven modeling, and clinical validation for women's health diagnostics.
- Joint leadership: Dr. Kevin Elias (Cleveland Clinic) and Dr. Todd Pappas (Aspira) will lead multidisciplinary teams.
- Initial five-year term; may be extended by mutual agreement; either party can terminate with 60 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/0000926617-26-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000037/awhl-20260520x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-26-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer